Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
21.7%
% of OZEM's 23 holdings also in PPH
20.8%
% of PPH's 27 holdings also in OZEM
Overlap by Weight
Sector Drift (OZEM minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.2% | 11.9% | 11.9% |
 |
NOVO-NORDISK A/S-SPONS ADR | 16.9% | 7.8% | 7.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.9% | 4.4% | 3.9% |
|
PFIZER INC | 3.0% | 4.2% | 3.0% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONSORED ADR | 2.1% | 4.6% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
OZEM Overweight Relative to PPH
|
NOVO-NORDISK A/S-SPONS ADR | 9.1% |
 |
ROCHE HOLDING LTD | 4.9% |
|
ZEALAND PHARMA A/S | 4.7% |
|
CHUGAI PHARMACEUTICAL CO LTD | 4.7% |
|
ALTIMMUNE, INC. | 4.6% |
|
VIKING THERAPEUTICS, INC. | 3.3% |
 |
INNOVENT BIOLOGICS, INC. | 3.2% |
|
AMGEN INC | 3.2% |
|
SCHOLAR ROCK HOLDING CORP. | 2.7% |
 |
HANMI PHARM CO LTD | 2.5% |
OZEM Underweight Relative to PPH
|
JOHNSON & JOHNSON | -6.8% |
|
MCKESSON CORP | -6.0% |
|
BRISTOL-MYERS SQUIBB CO | -5.8% |
|
ABBVIE INC | -5.7% |
|
AMERISOURCEBERGEN CORP | -5.1% |
|
NOVARTIS AG-ADR | -5.0% |
|
MERCK & CO. INC. | -4.8% |
|
ZOETIS INC | -4.6% |
 |
SANOFI-AVENTIS-ADR | -4.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.8% |